speb/financial-data huggingface dataset:
CCAVENUE.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 189300000.00
CCAVENUE.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CCAVENUE.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CCAVENUE.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 199100000.00
CCAVENUE.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.24
CCAVENUE.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 10110600000.00
CCAVENUE.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
CCAVENUE.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — +Operating Expense: 36113500000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 10615700000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — +Total Revenue: 39925800000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 11605200000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 320470000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 320470000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 892700000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 892700000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -2145350000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2145350000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 25272780000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 25272780000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -204720000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -204720000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Amortization: 417600000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 6916600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 2615240000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 2652235294.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 2455000000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Basic EPS: 0.85
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.20
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 6952300000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 2269390000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -3764100000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 199200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 199200000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 2789500000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2789500000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 3313300000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3313300000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 8514400000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 8514400000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -138400000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 1247750000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1247750000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 857000000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Change In Payable: 115100000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 283600000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -2895400000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -3912300000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Common Stock: 2789500000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 2789500000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 37354600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 37354600000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 7500000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Common Stock Payments: 0.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1202110000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1202100000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 1481900000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 390600000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Current Assets: 18764100000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 18764060000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 58400000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 58370000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Current Debt: 867000000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 867000000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 925320000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 925320000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 11782700000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 11782700000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 248410000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 248410000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Depreciation: 703600000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 703600000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 703600000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 178500000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 703600000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 178500000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 2683809524.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 2584210526.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Diluted EPS: 0.84
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.19
CCAVENUE.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 2254400000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 491000000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 790000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 400000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — EBIT: 3164800000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — EBIT: 814300000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — EBITDA: 3868400000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — EBITDA: 992800000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — End Cash Position: 3313300000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 684870000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 2089500000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -3043500000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -220600000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 39500000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 229200000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Goodwill: 16704590000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 16704590000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 24135290000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 24135400000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1097460000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1097460000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 3093200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3093200000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Gross Profit: 38443900000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 11214600000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Interest Expense: 82800000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 32300000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 82800000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 32300000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Interest Income: 424420000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -62100000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 364700000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 38880200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 38880200000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -6722400000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 6916600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 6916600000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 7500000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 140800000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 140810000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 658590000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 658590000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 799400000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 799400000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 122600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 122600000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 1081990000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 1081990000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Minority Interests: -105900000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -55800000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 7500000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -4200000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Net Income: 2254400000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Net Income: 491000000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 2254400000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 491000000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 2360300000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 546800000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2254400000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 491000000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2254400000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 491000000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 3020900000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 2360300000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 546800000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Net Interest Income: -82800000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -32300000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -2350500000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 555900000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 555900000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -82800000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -32300000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 1726600000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -6700000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Net PPE: 3093200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 3093200000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -3761100000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 13219200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 13219200000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 32210000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 32210000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2474700000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2474700000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 122630000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 3826500000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 950900000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Normalized Income: 2222311560.67
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 461702148.34
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 720600000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Operating Income: 2330400000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Operating Income: 598900000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Operating Revenue: 39925800000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 11605200000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 3106078169.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 3106078169.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 273300000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 7622600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 7622600000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 9246700000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 9246700000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 900490000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 34565100000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 7430700000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 7430800000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -432700000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 30000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 593300000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 71200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 71200000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 731400000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 199400000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 35409900000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 10437200000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Other Properties: 1891100000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 1891100000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 1734400000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1734400000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 5201100000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2596740000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Other Special Charges: -2420000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Payables: 10308330000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Payables: 10308330000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 58480000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 2071220000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Pretax Income: 3082000000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 782000000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 5900000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -3246000000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -3764100000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 1481900000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 390600000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 703600000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 178500000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 30070000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 2065390000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 9343360000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 9343360000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 895500000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 3000000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 262210000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Share Issued: 3119847845.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 3119847845.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Special Income Charges: 41900000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 41900000.00
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 147000000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 37354590000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 37354600000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 13219300000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 13219300000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 9811560.67
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 12602148.34
CCAVENUE.NS income_statement (annual, 2025-03-31) — Tax Provision: 721700000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 235200000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.23
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
CCAVENUE.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: 284400000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Total Assets: 53687040000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 53687040000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 38013200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 38013180000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1724800000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1724800000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 38436600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 38436600000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Total Expenses: 37595400000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 11006300000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 15250460000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 15250600000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 34923100000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 34922980000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3467900000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3467930000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 4550000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 58200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 58160000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 41900000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 41900000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 41900000.00
CCAVENUE.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 41900000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Treasury Shares Number: 13769676.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 13769676.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 413510000.00
CCAVENUE.NS balance_sheet (annual, 2025-03-31) — Working Capital: 6981400000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 6981530000.00
CCAVENUE.NS income_statement (annual, 2025-03-31) — Write Off: 70000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 11877700000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 12802100000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 2916666667.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.21
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 391200000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 176700000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 176700000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 2916666667.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.21
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 612500000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — EBIT: 813200000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — EBITDA: 989900000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 12410900000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 24300000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 24300000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 28200000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Net Income: 612500000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 612500000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 584300000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 612500000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 612500000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 584300000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -24300000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -24300000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 989900000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 612500000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Operating Income: 533200000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 12802100000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 263000000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 11701000000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 788900000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 391200000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 176700000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 204600000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 12268900000.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
CCAVENUE.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 18533200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 19649100000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 236900000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1427100000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 5667900000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 2892173913.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 0.23
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 295500000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 3146400000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 6824200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 13914700000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 3146400000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 41695000000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 1403100000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 341200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 26782600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 71900000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 491100000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 563000000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 15476900000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 54200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 187600000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 187600000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 2892173913.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.23
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 665200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — EBIT: 919900000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — EBITDA: 1107500000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 16705400000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 24963800000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3392200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 19307900000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 31700000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 31700000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 42186100000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 5667900000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 223600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 0.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 223600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 127600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 1730500000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -11300000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Net Income: 665200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 665200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 676500000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 665200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 665200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 676500000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -31700000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -31700000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 3392200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 16731200000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2823400000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1107500000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 665200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Operating Income: 774700000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 19649100000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 3481019690.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 10126500000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 13059300000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 38548600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 8258400000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1109700000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 59400000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 210600000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 18345600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 1989100000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1314300000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 7090500000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Payables: 359000000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 888200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 341200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 187600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 3496420770.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 41695000000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 16731200000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 211700000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 62136400000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 41695000000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 786600000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 43425500000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 18874400000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 18710900000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 35353800000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3234000000.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 122100000.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
CCAVENUE.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 15401080.00
CCAVENUE.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 11305700000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 22774000000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 23811900000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 2764615385.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.26
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 267600000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 185000000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 185000000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 2764615385.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.26
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 718800000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — EBIT: 919000000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1104000000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 23544300000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 31300000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 31300000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -79600000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Net Income: 718800000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 718800000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 798400000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 718800000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 718800000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 798400000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -31300000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -31300000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1136400000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 747940655.63
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Operating Income: 770300000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 23811900000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 162100000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 22589000000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 887700000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 267600000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 185000000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -32400000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -3259344.37
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 89300000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.10
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 23041600000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -32400000.00
CCAVENUE.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -32400000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — +Operating Expense: 77079400000.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 23894500000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — +Total Revenue: 81158500000.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 24895400000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 253700000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 253700000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1143100000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1143100000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 6693000000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 6693000000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 2968510638.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 2835000000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — Basic EPS: 0.94
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.28
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 3313300000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -3407800000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 303900000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 303900000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 3492300000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3492300000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 9132300000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 9132300000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 20746500000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 20746500000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -100000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -3644500000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Change In Payable: -66600000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -302800000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 1317400000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 5818900000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Common Stock: 3492300000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 3492300000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 47462200000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 47462200000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 6966700000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Common Stock Payments: -30900000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 5600000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 5600000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 1294600000.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 294600000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Current Assets: 34717400000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 34717400000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 81200000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 81200000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1328900000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1328900000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1410100000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1410100000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 17288600000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 17288600000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 66900000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 66900000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Depreciation: 767100000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 767100000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 767100000.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 217900000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 767100000.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 217900000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 3000430108.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 2835000000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — Diluted EPS: 0.93
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.28
CCAVENUE.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 2790400000.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 793800000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 0.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — EBIT: 3598200000.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — EBIT: 946200000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — EBITDA: 4365300000.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — EBITDA: 1164100000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — End Cash Position: 9132300000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 9567900000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 1957400000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 353300000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -900000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Goodwill: 16705400000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 16705400000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 27530200000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 27530200000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 3513400000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 3513400000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — Gross Profit: 79863900000.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 24600800000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — Interest Expense: 186300000.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 99000000.00
CCAVENUE.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 186300000.00
CCAVENUE.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 99000000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -157300000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 663700000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 51453600000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 51453600000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -9114200000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 6693000000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 6693000000.00
CCAVENUE.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 6966700000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 222700000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 222700000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 2662500000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2662500000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2885200000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2885200000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 166000000.00
CCAVENUE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 166000000.00
CCAVENUE.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 2310000000.00